Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/2000
09/20/2000CN1056526C Extract for giving up drug-taking
09/20/2000CN1056524C Plaster for treating burn and scald and its preparation method
09/20/2000CN1056522C Health-care tonic liquor and its producing method
09/20/2000CN1056521C Injection for curing edematous conjunctivitis of piglet
09/20/2000CN1056519C Medicine for prevention and treatment of iodine-deficient disease and preparation method thereof
09/20/2000CN1056518C Plaster for treatment of surgical diseases, e. g. cellulitis, tumor etc.
09/20/2000CN1056516C Traditional Chinese medicine preparation for treating cataract, glaucoma and optic actrophy
09/20/2000CN1056514C Quick blood-forming agent
09/20/2000CN1056503C High-nutrient biological synthetic functional health egg
09/19/2000US6121435 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
09/19/2000US6121044 Potent antigen presenting cell composition
09/19/2000US6121036 Purified, host-specific, nontoxic, wide host range, virulent preparation against staphylococcus, helicobacter, mycobacterium, streptococcus, klebsiella, enterobacter, proteus, bacteriodes, pseudomonas, escherichia and others
09/19/2000US6121035 Amino acid sequences; for screening drugs and producing antibodies
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6120763 Compositions and methods for enhanced tumor cell immunity in vivo
09/19/2000CA2300792A1 An agent for increasing chemokine production
09/19/2000CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed
09/19/2000CA2053242C Protease inhibitor
09/14/2000WO2000053795A1 Adipose-derived stem cells and lattices
09/14/2000WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053541A1 A vital matter and a producing method
09/14/2000WO2000053202A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
09/14/2000WO2000053201A1 Lactic acid bacteria strains capable of preventing diarrhoea
09/14/2000WO2000053200A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria
09/14/2000WO2000053199A1 Pharmaceutical and animal fodder comprising fermented fish
09/14/2000WO2000053198A1 Inhibitor of lipoxygenase pathways
09/14/2000WO2000053197A1 Matrix protein compositions for grafting
09/14/2000WO2000053196A1 Matrix protein compositions for induction of apoptosis
09/14/2000WO2000053195A1 Decolorized animal blood products and method of making same
09/14/2000WO2000053159A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
09/14/2000WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
09/14/2000WO2000030425A3 Method of using pon-1 to decrease atheroma formation
09/14/2000WO2000027883B1 A method of treating tumors using fas-induced apoptosis
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2366078A1 Adipose-derived stem cells and lattices
09/14/2000CA2364462A1 Decolorized animal blood products and method of making same
09/14/2000CA2364440A1 Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
09/14/2000CA2364435A1 Lactobacillus strains preventing diarrhoea pathogenic bacteria
09/14/2000CA2363593A1 Nucleic acid respiratory syncytial virus vaccines
09/14/2000CA2363134A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
09/13/2000EP1034788A1 Lactic acid bacteria strains capable of preventing diarrhea
09/13/2000EP1034787A1 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
09/13/2000EP1034786A1 Method for delivering direct feed microorganisms to poultry in ovo
09/13/2000EP1034288A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells
09/13/2000EP1034267A1 Compositions and methods for inducing gene expression
09/13/2000EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
09/13/2000EP1034255A1 Lineage restricted glial precursors from the central nervous system
09/13/2000EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3
09/13/2000EP1033993A1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine
09/13/2000EP1033953A1 Method of cross-linking keratin-based films, sheets, and bulk materials
09/13/2000CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response
09/13/2000CN1266351A Control of enterohemorrhagic E Coli 0157 : H7 in cattle by probiotic bacteria
09/13/2000CN1265918A A powder medicine and preparation process thereof
09/13/2000CN1265917A Medicine for treating lithiasis
09/13/2000CN1265904A Traditional Chinese medicinal pill with function of prolonging life
09/13/2000CN1265903A Traditional Chinese powder medicine for treating cough and preparation process thereof
09/13/2000CN1265900A Bear gallbladder lozenge and preparation process thereof
09/13/2000CN1265898A External medicine for treating tympanitis
09/13/2000CN1265892A Medicine for treating burn and preparation process thereof
09/13/2000CN1265891A Technoogies for producing inhibitant of tumor blood vessel formation
09/13/2000CN1056407C Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns
09/13/2000CN1056383C Chinese trichosanthes protein, preparation method and use in pharmacy
09/13/2000CN1056311C Pill for waist strengthening and anti-protrusion
09/13/2000CN1056307C Epiplesy curing powder
09/13/2000CN1056306C Plaster for treating traumatic injury and preparation process thereof
09/13/2000CN1056303C Zaohuang ointment for treating burn and preparation process thereof
09/13/2000CN1056299C External medicine for treating rheumatic and rheumatoid arthritis
09/13/2000CN1056296C Capsule for treating apoplexy
09/13/2000CN1056295C Tradtional Chinese medicine for balancing internal secretion
09/13/2000CN1056291C Traditional Chinese medicine for treating scorofula
09/13/2000CN1056287C Traditional Chinese medicine for reducing blood-lipid and its preparation process
09/13/2000CN1056286C Traditional Chinese medicine ointment for treating AIDS
09/13/2000CN1056284C Traditional Chinese medicinal preparation for treating epilepsy
09/13/2000CN1056280C Composition of tortoise and snake powder and preparation process thereof
09/13/2000CN1056272C Earthworm lactate nutrient solution and preparation method thereof
09/12/2000US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease
09/12/2000US6117913 Administering creosote or a phenolic derivative of creosote.
09/12/2000US6117675 Retinal stem cells
09/12/2000US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration
09/12/2000CA2020209C Low viscosity, highly concentrated surfactant suspension
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/09/2000CA2299205A1 Super-oxygenated water solutions and methods of use
09/08/2000WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000WO2000052187A2 Enhanced system for construction of adenovirus vectors
09/08/2000WO2000052184A1 Anti-neoplastic compositions and uses thereof
09/08/2000WO2000052149A1 Introducing a biological material into a patient
09/08/2000WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
09/08/2000WO2000052143A2 The isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000051635A2 Emulsan and emulsan analogs immunization formulations and use
09/08/2000WO2000051630A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent
09/08/2000WO2000051527A1 In vitro production of transplantable cartilage tissue